Agnoli G C, Borgatti R, Cacciari M, Ikonomu E, Lenzi P, Marinelli M
Cattedra di Medicina Interna, Università, Bologna, Italy.
Clin Physiol. 1994 Mar;14(2):205-22. doi: 10.1111/j.1475-097x.1994.tb00507.x.
The role of the renin-angiotensin system in renal hypokalaemic dysfunction has been investigated by evaluating the effects of the angiotensin (AT)-converting enzyme inhibition by enalapril. Healthy women were studied either in normal potassium balance (N3, n = 6) or moderate potassium depletion (KD3, n = 6). Potassium depletion (KD) was induced by low potassium dietary intake (greater than or equal to 10 mmol per day) and natriuretic treatment associated with replacement of net NaCl and water losses; the cumulative potassium deficit achieved was 214 +/- 54 mmol. The renal function and the urinary excretions of some prostanoids (PGE2, 6-keto-PGF1 alpha, TxB2) were evaluated during hypotonic polyuria (oral water load) and subsequent moderate antidiuresis (lysine-8-vasopressin (LVP) low-dose infusion). Paired studies were performed in absence (control) and presence of enalapril. Basal plasma renin activity (PRA) and urinary aldosterone excretion were determined before the water load of control studies. Renal dysfunction typical of chronic KD occurred in the KD3 group, i.e. increase in PRA, decrease in creatinine clearance, depression of the diuretic response to water load, inhibition of distal fractional chloride reabsorption, and blunted efficacy of LVP in increasing the urinary solute concentration. The urinary prostanoid excretions were reduced. Basal urinary aldosterone excretion was not changed significantly. In KD3 group enalapril decreased mean arterial pressure (MAP), increased the plasma potassium concentration, improved the diuretic response to water load and corrected the impairment of the distal fractional chloride reabsorption. Despite the decrease in MAP enalapril did not affect significantly the creatinine clearance. Neither urinary prostanoid excretions nor the renal response to LVP were affected by the drug. The data suggest that in KD the increased activity of the renin-angiotensin system affected the renal function both through direct effects and through effects dependent on the angiotensin-supported secretions of aldosterone and probably of vasopressin. Finally, by comparing the effects of enalapril and indomethacin in experimental groups with an equivalent degree of KD, evidence is provided in favour of the interaction between renin-angiotensin and prostanoid systems in controlling the glomerular filtration rate and the salt and water handling by renal tubules.
通过评估依那普利对血管紧张素(AT)转换酶的抑制作用,研究了肾素 - 血管紧张素系统在肾性低钾性功能障碍中的作用。对健康女性进行了研究,她们分别处于正常钾平衡状态(N3,n = 6)或中度钾缺乏状态(KD3,n = 6)。通过低钾饮食摄入(每天大于或等于10 mmol)和与净NaCl和水分丢失替代相关的利钠治疗诱导钾缺乏(KD);累积钾缺乏量达到214±54 mmol。在低渗性多尿期(口服水负荷)和随后的中度抗利尿期(赖氨酸 - 8 - 血管加压素(LVP)低剂量输注)评估肾功能和一些前列腺素(PGE2、6 - 酮 - PGF1α、TxB2)的尿排泄。在无依那普利(对照)和有依那普利的情况下进行配对研究。在对照研究的水负荷前测定基础血浆肾素活性(PRA)和尿醛固酮排泄。KD3组出现了慢性KD典型的肾功能障碍,即PRA升高、肌酐清除率降低、对水负荷的利尿反应减弱、远端氯分数重吸收受抑制以及LVP增加尿溶质浓度的效力减弱。尿前列腺素排泄减少。基础尿醛固酮排泄无明显变化。在KD3组中,依那普利降低平均动脉压(MAP),增加血浆钾浓度,改善对水负荷的利尿反应并纠正远端氯分数重吸收的损害。尽管MAP降低,但依那普利对肌酐清除率无明显影响。该药物既不影响尿前列腺素排泄,也不影响肾脏对LVP的反应。数据表明,在KD中,肾素 - 血管紧张素系统活性增加通过直接作用以及依赖于血管紧张素支持的醛固酮可能还有血管加压素分泌的作用影响肾功能。最后,通过比较依那普利和吲哚美辛在同等程度KD实验组中的作用,为肾素 - 血管紧张素系统和前列腺素系统在控制肾小球滤过率以及肾小管对盐和水的处理方面的相互作用提供了证据。